| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |